Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2000
11/16/2000CA2369605A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/16/2000CA2369577A1 Method for detecting microorganisms in a sample
11/16/2000CA2369422A1 Regulation of viral gene expression
11/16/2000CA2336437A1 A process of cell reprogramming through production of a heterokaryon
11/16/2000CA2333434A1 Maize rad50 orthologue and uses thereof
11/15/2000EP1052288A1 Complex for transferring an anionic substance of interest into a cell
11/15/2000EP1052287A2 Complex for transferring an anionic substance of interest into a cell
11/15/2000EP1052286A2 Growth hormone and growth hormone releasing hormone compositions
11/15/2000EP1051625A1 Assessing risk for integrin antagonist/agonist mediated diseases
11/15/2000EP1051620A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
11/15/2000EP1051523A2 Nucleic acid analysis method
11/15/2000EP1051522A2 Method for quantitatively analyzing tumor cells in a body fluid and test kits suited therefor
11/15/2000EP1051521A2 Method of screening therapeutic agents
11/15/2000EP1051520A1 Improved method for the isolation of nucleic acid
11/15/2000EP1051519A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions
11/15/2000EP1051516A1 Gene expression methods for screening compounds
11/15/2000EP1051515A2 Modified nucleic acid probes and uses thereof
11/15/2000EP1051514A1 Method of isolation of rna-binding compounds
11/15/2000EP1051513A1 Polymeric arrays and methods for their use in binding assays
11/15/2000EP1051512A1 Method for detecting and identifying mutations
11/15/2000EP1051508A1 Pancreatic eukaryotic translation initiation factor-2alpha kinase
11/15/2000EP1051507A1 Antigen-specific cells, methods of generating these cells and uses thereof
11/15/2000EP1051504A2 Riboflavin biosynthesis genes from plants and uses thereof
11/15/2000EP1051503A1 METHOD FOR PRODUCING, BY PLANT CELLS, $g(a) 1?-ANTITRYPSIN AND ITS ALLELES, AND PRODUCTS CONTAINING THE RESULTING $g(a) 1?-ANTITRYPSIN
11/15/2000EP1051502A2 HIGHLY EFFICIENT CONTROLLED EXPRESSION OF EXOGENOUS GENES IN $i(E. COLI)
11/15/2000EP1051501A1 Nucleic acid molecule encoding a cephalosporin acetylesterase
11/15/2000EP1051500A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/15/2000EP1051499A2 Tyrosylprotein sulfotransferase polypeptides and polynucleotides
11/15/2000EP1051498A1 Poly adp-ribose polymerase gene and its uses
11/15/2000EP1051497A2 Human protein kinase molecules
11/15/2000EP1051496A1 Whisker-mediated transformation of plant cell aggregates and plant tissues and regeneration of plants thereof
11/15/2000EP1051495A2 Recombinant mistletoe lectines
11/15/2000EP1051494A1 Methods and reagents for decreasing allergic reactions
11/15/2000EP1051493A2 Method for producing antibody fragments
11/15/2000EP1051492A1 Recombinant proteins from hgf and msp
11/15/2000EP1051491A1 EQUINE Fc EPSILON RECEPTOR ALPHA CHAIN NUCLEIC ACID MOLECULES, CORRESPONDING PROTEINS AND USES THEREOF
11/15/2000EP1051490A2 Modulation of cell proliferation, methods and reagents
11/15/2000EP1051489A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
11/15/2000EP1051488A2 Human growth factor homologs
11/15/2000EP1051487A1 Placental protein 13
11/15/2000EP1051486A1 Gtpase derived from human lymph nodes that effects the morphology and cytoskeleton organization of endothelial cells
11/15/2000EP1051485A1 Trek-1 like two pore potassium channel
11/15/2000EP1051484A1 Gene regulator fusion proteins and methods of using the same for determining resistance of a protein to a drug targeted there against
11/15/2000EP1051483A1 A method of isolating a peptide which immunologically mimics microbial carbohydrates including group b streptococcal carbohydrates and the use thereof
11/15/2000EP1051482A1 Cytotoxic heteromeric protein combinatorial libraries
11/15/2000EP1051481A1 Secreted proteins and polynucleotides encoding them
11/15/2000EP1051479A1 Novel steroid-activated nuclear receptors and uses therefor
11/15/2000EP1051434A1 G protein-coupled receptor
11/15/2000EP1051432A2 Method for reducing immunogenicity of proteins
11/15/2000EP1051430A2 Array fabrication methods
11/15/2000EP1051429A1 Ldl related protein and uses thereof
11/15/2000EP1051428A1 Human cystatin f
11/15/2000EP1051427A1 Spoil protein and nucleic acid molecules and uses therefor
11/15/2000EP1051426A1 67 human secreted proteins
11/15/2000EP1051245A1 Method of quality control in manufacturing processes
11/15/2000EP1051244A1 Method and articles for transfection of genetic material
11/15/2000EP0832191A4 Recombinant viral nucleic acids
11/15/2000EP0828826A4 Plant promoter activated by fungal infection
11/15/2000EP0808374A4 Method for modulating processes mediated by farnesoid activated receptors
11/15/2000EP0771359A4 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors
11/15/2000EP0765343B1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
11/15/2000EP0716710B1 Methods of suppressing immune response by gene therapy
11/15/2000EP0658168B1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
11/15/2000EP0601129B1 Morphogenic protein screening method
11/15/2000CN1273609A Method and compositions for detection or quantification of nucleic acid species
11/15/2000CN1273606A The use of mixed duplex oligonucleotides to effect localized genetic changes in plants
11/15/2000CN1273605A Mass production method of antimicrobial peptide and DNA construct and expression system thereof
11/15/2000CN1273604A Antifreeze proteins, DNA and expression system
11/15/2000CN1273603A Attenuated respiratory syncytial viruses
11/15/2000CN1273602A Transgenic mammals which produce oligosaccharides in their milk
11/15/2000CN1273601A Enzymes mixture
11/15/2000CN1273600A Avian primordial germ cell (PGC) cell line and method for long term culturing thereof
11/15/2000CN1273599A Production of avian embryonic germ (EG) cell lines by prolonged culturing of PGCs,use thereof for cloning and chimerization
11/15/2000CN1273588A Amino acid sequences for therapeutical and prophylacticapplications to disedses due to i (clostridium difficile) toxinc
11/15/2000CN1273248A Efficient gene engineering process for preparing polypeptide medicines
11/15/2000CN1273127A Genetically engineered body for preparing somatostatin subunit vaccine
11/15/2000CN1058525C Transgene mammal cell system representing protein in surface antigen of hepatitis B virus
11/15/2000CN1058524C Heat tolerant phytases
11/15/2000CN1058523C Genes for butyrobetaine/crotonobetaine-L-carnitine metabolism and their use for microbiological production of L-carine
11/14/2000US6147282 Method of controlling the fertility of a plant
11/14/2000US6147281 Antipathogenic peptides and compositions containing same
11/14/2000US6147280 Preparing carbohydrates with reduced polymerization activity; transforming plant cell with an expression construct which codes a fructosyltransferase, regenerate transgenic plant, culture transgenic plant and isolate carbohydrates
11/14/2000US6147279 Inhibition of gene expression
11/14/2000US6147278 Plant vectors
11/14/2000US6147277 Nucleotide sequences which encode an enzymatic protein associate with hydrolysis of starch; for use during horticulture and preferential plant selection
11/14/2000US6147276 Quiescent cell populations for nuclear transfer in the production of non-human mammals and non-human mammalian embryos
11/14/2000US6147275 Corticotropin releasing factor receptor 1-deficient mice
11/14/2000US6147211 Method for treating cyclic phosphate compound
11/14/2000US6147204 Complex for targeting therapeutic or diagnostic agents to preferential biological target
11/14/2000US6147203 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
11/14/2000US6147202 Nucleotide sequences coding erythrocyte proteins; for utilization in blood transfusions
11/14/2000US6147200 2'-O-acetamido modified monomers and oligomers
11/14/2000US6147194 Purified monoclonal antibody which binds inosine 5'-monophosphate dehydrogenase polypeptide which is encoded by a defined nucleotide sequence; immunoassays for detection
11/14/2000US6147192 Proteins associated with weight control; for the treatmen of eating disorders
11/14/2000US6147190 Protein associated with activating cell propagation; for the treatment of a nervous system disorders; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147055 Cancer treatment method utilizing plasmids suitable for IL-2 expression
11/14/2000US6147052 Method of differentiating erythrocyte progenitor cells
11/14/2000US6147050 5-lipoxygenase-activating protein II
11/14/2000US6146903 Method for determination of water treatment polymers
11/14/2000US6146894 Method for generating hypermutable organisms
1 ... 3156 3157 3158 3159 3160 3161 3162 3163 3164 3165 3166 3167 3168 3169 3170 3171 3172 3173 3174 3175 3176 ... 4023